Annual Total Long Term Liabilities
$234.19 M
+$8.48 M+3.76%
December 31, 2023
Summary
- As of February 7, 2025, XERS annual total long term liabilities is $234.19 million, with the most recent change of +$8.48 million (+3.76%) on December 31, 2023.
- During the last 3 years, XERS annual total long term liabilities has risen by +$137.01 million (+140.98%).
- XERS annual total long term liabilities is now at all-time high.
Performance
XERS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$258.41 M
-$17.12 M-6.21%
September 30, 2024
Summary
- As of February 7, 2025, XERS quarterly total long term liabilities is $258.41 million, with the most recent change of -$17.12 million (-6.21%) on September 30, 2024.
- Over the past year, XERS quarterly long term liabilities has increased by +$21.53 million (+9.09%).
- XERS quarterly long term liabilities is now -6.21% below its all-time high of $275.53 million, reached on June 30, 2024.
Performance
XERS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
XERS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.8% | +9.1% |
| 3 y3 years | +141.0% | +9.1% |
| 5 y5 years | +579.8% | +9.1% |
XERS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +80.0% | -6.2% | +98.6% |
| 5 y | 5-year | at high | +248.4% | -6.2% | +284.5% |
| alltime | all time | at high | +579.8% | -6.2% | +1223.6% |
Xeris Biopharma Holdings Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $258.41 M(-6.2%) |
| Jun 2024 | - | $275.53 M(+1.0%) |
| Mar 2024 | - | $272.71 M(+16.4%) |
| Dec 2023 | $234.19 M(+3.8%) | $234.19 M(-1.1%) |
| Sep 2023 | - | $236.88 M(+0.6%) |
| Jun 2023 | - | $235.46 M(+12.2%) |
| Mar 2023 | - | $209.89 M(-7.0%) |
| Dec 2022 | $225.71 M(+73.5%) | $225.71 M(+25.8%) |
| Sep 2022 | - | $179.42 M(-0.4%) |
| Jun 2022 | - | $180.13 M(+3.1%) |
| Mar 2022 | - | $174.68 M(+34.3%) |
| Dec 2021 | $130.09 M | $130.09 M(+34.9%) |
| Sep 2021 | - | $96.44 M(+0.3%) |
| Jun 2021 | - | $96.14 M(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $95.83 M(-1.4%) |
| Dec 2020 | $97.18 M(+44.6%) | $97.18 M(-24.7%) |
| Sep 2020 | - | $129.02 M(+8.7%) |
| Jun 2020 | - | $118.64 M(+75.7%) |
| Mar 2020 | - | $67.51 M(+0.4%) |
| Dec 2019 | $67.21 M(+95.1%) | $67.21 M(+0.8%) |
| Sep 2019 | - | $66.65 M(+75.0%) |
| Jun 2019 | - | $38.09 M(-5.9%) |
| Mar 2019 | - | $40.46 M(+17.5%) |
| Dec 2018 | $34.45 M(-64.8%) | $34.45 M(+0.5%) |
| Sep 2018 | - | $34.26 M(+73.7%) |
| Jun 2018 | - | $19.73 M(+1.1%) |
| Mar 2018 | - | $19.52 M(-80.1%) |
| Dec 2017 | $97.97 M(+55.7%) | $97.97 M |
| Dec 2016 | $62.94 M | - |
FAQ
- What is Xeris Biopharma Holdings annual total long term liabilities?
- What is the all time high annual total long term liabilities for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual total long term liabilities year-on-year change?
- What is Xeris Biopharma Holdings quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly long term liabilities year-on-year change?
What is Xeris Biopharma Holdings annual total long term liabilities?
The current annual total long term liabilities of XERS is $234.19 M
What is the all time high annual total long term liabilities for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual total long term liabilities is $234.19 M
What is Xeris Biopharma Holdings annual total long term liabilities year-on-year change?
Over the past year, XERS annual total long term liabilities has changed by +$8.48 M (+3.76%)
What is Xeris Biopharma Holdings quarterly total long term liabilities?
The current quarterly long term liabilities of XERS is $258.41 M
What is the all time high quarterly long term liabilities for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly total long term liabilities is $275.53 M
What is Xeris Biopharma Holdings quarterly long term liabilities year-on-year change?
Over the past year, XERS quarterly total long term liabilities has changed by +$21.53 M (+9.09%)